{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:58:49Z","timestamp":1793699929663,"version":"4.5.1"},"reference-count":127,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T00:00:00Z","timestamp":1523318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,20]]},"DOI":"10.1093\/schbul\/sby024","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T15:14:17Z","timestamp":1522250057000},"page":"973-982","source":"Crossref","is-referenced-by-count":618,"title":["Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations"],"prefix":"10.1093","volume":"44","author":[{"given":"Norbert","family":"M\u00fcller","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Psychotherapy Ludwig Maximilian University and Marion von Tessin Memory Center, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,4,10]]},"reference":[{"key":"key\n\t\t\t\t20180820115501_CIT0001","doi-asserted-by":"crossref","DOI":"10.1201\/9781315533247","volume-title":"Janeway\u2019s Immunobiology","author":"Murphy","year":"2016","edition":"9th"},{"key":"key\n\t\t\t\t20180820115501_CIT0002","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1212\/01.wnl.0000275234.43506.9b","article-title":"Dual role of inflammation in CNS disease","volume":"68","author":"Hohlfeld","year":"2007","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180820115501_CIT0003","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury in multiple sclerosis","volume":"128","author":"Kutzelnigg","year":"2005","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180820115501_CIT0004","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jns.2008.06.032","article-title":"Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis","volume":"274","author":"Meinl","year":"2008","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20180820115501_CIT0005","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.neuroscience.2008.09.009","article-title":"Neuro-immune crosstalk in CNS diseases","volume":"158","author":"Kerschensteiner","year":"2009","journal-title":"Neuroscience"},{"key":"key\n\t\t\t\t20180820115501_CIT0006","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1177\/1352458514533230","article-title":"The role of microglial activation in disease progression","volume":"20","author":"Correale","year":"2014","journal-title":"Mult Scler"},{"key":"key\n\t\t\t\t20180820115501_CIT0007","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2350-6-7","article-title":"Theories of schizophrenia: a genetic-inflammatory-vascular synthesis","volume":"6","author":"Hanson","year":"2005","journal-title":"BMC Med Genet"},{"key":"key\n\t\t\t\t20180820115501_CIT0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2012.10.008","article-title":"Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia","volume":"42","author":"Anderson","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0009","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00319661","article-title":"Psychiatric disorders in the encephalitic form of multiple sclerosis","volume":"237","author":"Felgenhauer","year":"1990","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t20180820115501_CIT0010","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000073062","article-title":"Schizophreniform disorder with cerebrospinal fluid PCR positivity for herpes simplex virus type 1","volume":"50","author":"Chiveri","year":"2003","journal-title":"Eur Neurol"},{"key":"key\n\t\t\t\t20180820115501_CIT0011","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9343(82)90751-3","article-title":"Herpes simplex type 2 virus encephalitis presenting as psychosis","volume":"73","author":"Oommen","year":"1982","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20180820115501_CIT0012","first-page":"1239","article-title":"[An adult case suspected of recurrent measles encephalitis with psychiatric symptoms]","volume":"105","author":"Hiroshi","year":"2003","journal-title":"Seishin Shinkeigaku Zasshi"},{"key":"key\n\t\t\t\t20180820115501_CIT0013","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1176\/appi.ajp.157.12.2036","article-title":"The psychiatric symptoms of rheumatic fever","volume":"157","author":"Mercadante","year":"2000","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0014","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00787-006-0566-z","article-title":"Psychosis following acute Sydenham\u2019s chorea","volume":"16","author":"Teixeira","year":"2007","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/15622970601182652","article-title":"Chain reaction or time bomb: a neuropsychiatric-developmental\/neurodevelopmental formulation of tourettisms, pervasive developmental disorder, and schizophreniform symptomatology associated with PANDAS","volume":"8","author":"Kerbeshian","year":"2007","journal-title":"World J Biol Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0016","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s00115-006-2178-8","article-title":"Therapy-resistant depression with fatigue. A case of presumed streptococcal-associated autoimmune disorder","volume":"78","author":"Bechter","year":"2007","journal-title":"Nervenarzt"},{"key":"key\n\t\t\t\t20180820115501_CIT0017","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0006-3223(92)90160-2","article-title":"Depression as a cerebral manifestation of scleroderma: immunological findings in serum and cerebrospinal fluid","volume":"31","author":"M\u00fcller","year":"1992","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0018","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0920-9964(93)90054-M","article-title":"Cerebral involvement of scleroderma presenting as schizophrenia-like psychosis","volume":"10","author":"M\u00fcller","year":"1993","journal-title":"Schizophr Res"},{"key":"key\n\t\t\t\t20180820115501_CIT0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00290244","article-title":"Diagnosis and pathogenesis of CNS lupus","volume":"11","author":"van Dam","year":"1991","journal-title":"Rheumatol Int"},{"key":"key\n\t\t\t\t20180820115501_CIT0020","doi-asserted-by":"crossref","first-page":"R506","DOI":"10.1016\/j.cub.2008.04.047","article-title":"Microglia","volume":"18","author":"Soulet","year":"2008","journal-title":"Curr Biol"},{"key":"key\n\t\t\t\t20180820115501_CIT0021","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/brbi.2000.0613","article-title":"Cytokine-induced sickness behavior: where do we stand","volume":"15","author":"Dantzer","year":"2001","journal-title":"Brain Behav Immun"},{"key":"key\n\t\t\t\t20180820115501_CIT0022","first-page":"695","article-title":"Pro- versus anti-inflammatory cytokines: myth or reality","volume":"47","author":"Cavaillon","year":"2001","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"key\n\t\t\t\t20180820115501_CIT0023","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbi.2006.08.004","article-title":"Stress primes microglia to the presence of systemic inflammation: implications for environmental influences on the brain","volume":"21","author":"Perry","year":"2007","journal-title":"Brain Behav Immun"},{"key":"key\n\t\t\t\t20180820115501_CIT0024","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.iac.2009.02.007","article-title":"Age and neuroinflammation: a lifetime of psychoneuroimmune consequences","volume":"29","author":"Godbout","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"key\n\t\t\t\t20180820115501_CIT0025","doi-asserted-by":"crossref","first-page":"9275","DOI":"10.1523\/JNEUROSCI.2614-05.2005","article-title":"Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration","volume":"25","author":"Cunningham","year":"2005","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20180820115501_CIT0026","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000156474","article-title":"Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress","volume":"15","author":"Sparkman","year":"2008","journal-title":"Neuroimmunomodulation"},{"key":"key\n\t\t\t\t20180820115501_CIT0027","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbi.2006.03.005","article-title":"Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses","volume":"21","author":"Frank","year":"2007","journal-title":"Brain Behav Immun"},{"key":"key\n\t\t\t\t20180820115501_CIT0028","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11481-011-9299-y","article-title":"A lifespan approach to neuroinflammatory and cognitive disorders: a critical role for glia","volume":"7","author":"Bilbo","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"key":"key\n\t\t\t\t20180820115501_CIT0029","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1749-6632.1998.tb09555.x","article-title":"Interleukin-1, but not stress, stimulates glucocorticoid output during early postnatal life in mice","volume":"840","author":"Furukawa","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20180820115501_CIT0030","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1210\/endo.133.6.8243274","article-title":"Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis","volume":"133","author":"Zhou","year":"1993","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20180820115501_CIT0031","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/07853890310004075","article-title":"Cytokines, stress and depressive illness: brain-immune interactions","volume":"35","author":"Anisman","year":"2003","journal-title":"Ann Med"},{"key":"key\n\t\t\t\t20180820115501_CIT0032","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1046\/j.1460-9568.2002.01936.x","article-title":"Sensitization to the neuroendocrine, central monoamine and behavioural effects of murine tumor necrosis factor-alpha: peripheral and central mechanisms","volume":"15","author":"Hayley","year":"2002","journal-title":"Eur J Neurosci"},{"key":"key\n\t\t\t\t20180820115501_CIT0033","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jneuroim.2005.09.012","article-title":"Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation","volume":"171","author":"Nair","year":"2006","journal-title":"J Neuroimmunol"},{"key":"key\n\t\t\t\t20180820115501_CIT0034","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1037\/0021-843X.86.2.103","article-title":"Vulnerability\u2013a new view of schizophrenia","volume":"86","author":"Zubin","year":"1977","journal-title":"J Abnorm Psychol"},{"key":"key\n\t\t\t\t20180820115501_CIT0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/mp.2012.2","article-title":"The evolutionary significance of depression in pathogen host defense (PATHOS-D)","volume":"18","author":"Raison","year":"2013","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0036","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0920-9964(95)00073-9","article-title":"Fibrin degradation products in post mortem brain tissue of schizophrenics: a possible marker for underlying inflammatory processes","volume":"19","author":"K\u00f6rschenhausen","year":"1996","journal-title":"Schizophr Res"},{"key":"key\n\t\t\t\t20180820115501_CIT0037","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/elps.1150120706","article-title":"Analysis of cerebrospinal fluid from patients with psychiatric and neurological disorders by two-dimensional electrophoresis: identification of disease-associated polypeptides as fibrin fragments","volume":"12","author":"Wildenauer","year":"1991","journal-title":"Electrophoresis"},{"key":"key\n\t\t\t\t20180820115501_CIT0038","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1586\/14737175.6.7.1017","article-title":"Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders","volume":"6","author":"M\u00fcller","year":"2006","journal-title":"Expert Rev Neurother"},{"key":"key\n\t\t\t\t20180820115501_CIT0039","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/schbul\/sbx035","article-title":"Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder, and depression","volume":"44","author":"Wang","year":"2018","journal-title":"Schizophr Bull"},{"key":"key\n\t\t\t\t20180820115501_CIT0041","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.npbr.2013.04.004","article-title":"The mild encephalitis concept for psychiatric disorders revisited in the light of current psychoneuroimmunological findings","volume":"19","author":"Mueller","year":"2013","journal-title":"Neurol Psychiatry Brain Res"},{"key":"key\n\t\t\t\t20180820115501_CIT0042","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/157339510791823673","article-title":"Immune system and schizophrenia","volume":"6","author":"M\u00fcller","year":"2010","journal-title":"Curr Immunol Rev"},{"key":"key\n\t\t\t\t20180820115501_CIT0043","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0044","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0893-133X(88)90012-7","article-title":"The current status of the dopamine hypothesis of schizophrenia","volume":"1","author":"Carlsson","year":"1988","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t20180820115501_CIT0045","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/exnr.1998.6715","article-title":"Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines","volume":"149","author":"Ling","year":"1998","journal-title":"Exp Neurol"},{"key":"key\n\t\t\t\t20180820115501_CIT0046","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1749-6632.1998.tb09556.x","article-title":"Administration of interleukin-1 at birth affects dopaminergic neurons in adult mice","volume":"840","author":"Kabiersch","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20180820115501_CIT0047","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s004410051285","article-title":"Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons","volume":"296","author":"Potter","year":"1999","journal-title":"Cell Tissue Res"},{"key":"key\n\t\t\t\t20180820115501_CIT0048","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0736-5748(97)00029-4","article-title":"Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro","volume":"15","author":"Jarskog","year":"1997","journal-title":"Int J Dev Neurosci"},{"key":"key\n\t\t\t\t20180820115501_CIT0049","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1017\/S1461145708009206","article-title":"Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia","volume":"12","author":"Winter","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"key\n\t\t\t\t20180820115501_CIT0050","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nri2318","article-title":"Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections","volume":"8","author":"Nikolich-Zugich","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"key\n\t\t\t\t20180820115501_CIT0051","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/npp.2013.115","article-title":"Chronic interferon-\u03b1 decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates","volume":"38","author":"Felger","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t20180820115501_CIT0052","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0920-9964(94)00045-A","article-title":"Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology","volume":"14","author":"M\u00fcller","year":"1995","journal-title":"Schizophr Res"},{"key":"key\n\t\t\t\t20180820115501_CIT0053","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0031-6997(25)00441-7","article-title":"Neuropharmacology of quinolinic and kynurenic acids","volume":"45","author":"Stone","year":"1993","journal-title":"Pharmacol Rev"},{"key":"key\n\t\t\t\t20180820115501_CIT0054","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-3-211-73574-9_33","article-title":"The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view","author":"Muller","year":"2007","journal-title":"J Neural Transm Suppl"},{"key":"key\n\t\t\t\t20180820115501_CIT0055","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/138161211795049552","article-title":"Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects","volume":"17","author":"M\u00fcller","year":"2011","journal-title":"Curr Pharm Des"},{"key":"key\n\t\t\t\t20180820115501_CIT0056","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/2013.jamapsychiatry.86","article-title":"Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis","volume":"70","author":"Steiner","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0057","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S1474-4422(08)70225-4","article-title":"Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults","volume":"7","author":"Vincent","year":"2008","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20180820115501_CIT0058","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0304-3940(01)02242-X","article-title":"Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia","volume":"313","author":"Erhardt","year":"2001","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20180820115501_CIT0059","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/schbul\/sbq086","article-title":"Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia","volume":"38","author":"Linderholm","year":"2012","journal-title":"Schizophr Bull"},{"key":"key\n\t\t\t\t20180820115501_CIT0060","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0006-3223(01)01078-2","article-title":"Increased cortical kynurenate content in schizophrenia","volume":"50","author":"Schwarcz","year":"2001","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0061","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/schbul\/sbq112","article-title":"Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia","volume":"37","author":"Sathyasaikumar","year":"2011","journal-title":"Schizophr Bull"},{"key":"key\n\t\t\t\t20180820115501_CIT0062","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S1461145708009383","article-title":"Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia","volume":"12","author":"Olsson","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"key\n\t\t\t\t20180820115501_CIT0063","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1017\/S1461145710001689","article-title":"3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia","volume":"14","author":"Condray","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"key\n\t\t\t\t20180820115501_CIT0064","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.bbi.2011.05.005","article-title":"Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-na\u00efve and medication-free schizophrenic patients","volume":"25","author":"Myint","year":"2011","journal-title":"Brain Behav Immun"},{"key":"key\n\t\t\t\t20180820115501_CIT0065","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00702-005-0432-z","article-title":"Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain","volume":"113","author":"Ceresoli-Borroni","year":"2006","journal-title":"J Neural Transm (Vienna)"},{"key":"key\n\t\t\t\t20180820115501_CIT0066","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/archpsyc.58.11.1032","article-title":"Maternal infections and subsequent psychosis among offspring","volume":"58","author":"Buka","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0067","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1001\/archpsyc.56.11.993","article-title":"Exposure to prenatal and childhood infections and the risk of schizophrenia: suggestions from a study of sibship characteristics and influenza prevalence","volume":"56","author":"Westergaard","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0068","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00213-009-1504-9","article-title":"Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia","volume":"206","author":"Meyer","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"key":"key\n\t\t\t\t20180820115501_CIT0069","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pharmthera.2011.06.003","article-title":"Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative\/cognitive symptoms and beyond","volume":"132","author":"Meyer","year":"2011","journal-title":"Pharmacol Ther"},{"key":"key\n\t\t\t\t20180820115501_CIT0070","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/sj.mp.4000956","article-title":"Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms","volume":"6","author":"Pearce","year":"2001","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0071","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.biopsych.2007.09.022","article-title":"Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring","volume":"63","author":"Buka","year":"2008","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0072","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archpsyc.61.8.774","article-title":"Serologic evidence of prenatal influenza in the etiology of schizophrenia","volume":"61","author":"Brown","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0073","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1176\/appi.ajp.157.3.438","article-title":"Nonaffective psychosis after prenatal exposure to rubella","volume":"157","author":"Brown","year":"2000","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0074","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/schbul\/sbn121","article-title":"Association between prenatal exposure to bacterial infection and risk of schizophrenia","volume":"35","author":"S\u00f8rensen","year":"2009","journal-title":"Schizophr Bull"},{"key":"key\n\t\t\t\t20180820115501_CIT0075","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/ajp.2006.163.5.927","article-title":"Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia","volume":"163","author":"Babulas","year":"2006","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0076","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1176\/appi.ajp.162.4.767","article-title":"Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring","volume":"162","author":"Brown","year":"2005","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0077","first-page":"183","article-title":"Maternal infection during pregnancy and schizophrenia","volume":"33","author":"Boksa","year":"2008","journal-title":"J Psychiatry Neurosci"},{"key":"key\n\t\t\t\t20180820115501_CIT0078","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00406-004-0431-3","article-title":"Childhood meningitis, brain maturation and the risk of psychosis","volume":"254","author":"Gattaz","year":"2004","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"key\n\t\t\t\t20180820115501_CIT0079","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1176\/appi.ajp.2007.07101637","article-title":"The risk for schizophrenia from childhood and adult infections","volume":"165","author":"Brown","year":"2008","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1176\/appi.ajp.2007.07050740","article-title":"Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects","volume":"165","author":"Dalman","year":"2008","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0081","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1128\/CMR.8.1.131","article-title":"Viruses, schizophrenia, and bipolar disorder","volume":"8","author":"Yolken","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20180820115501_CIT0082","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00406-004-0481-6","article-title":"Antibodies to infectious agents in individuals with recent onset schizophrenia","volume":"254","author":"Leweke","year":"2004","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"key\n\t\t\t\t20180820115501_CIT0083","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3109\/15622971003653246","article-title":"The association of infectious agents and schizophrenia","volume":"11","author":"Krause","year":"2010","journal-title":"World J Biol Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0084","doi-asserted-by":"crossref","first-page":"10695","DOI":"10.1523\/JNEUROSCI.2178-07.2007","article-title":"Maternal immune activation alters fetal brain development through interleukin-6","volume":"27","author":"Smith","year":"2007","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20180820115501_CIT0085","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","article-title":"Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study","volume":"71","author":"Khandaker","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0086","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1176\/appi.ajp.161.5.889","article-title":"Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring","volume":"161","author":"Brown","year":"2004","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0087","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.schres.2010.05.014","article-title":"Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8","volume":"121","author":"Ellman","year":"2010","journal-title":"Schizophr Res"},{"key":"key\n\t\t\t\t20180820115501_CIT0088","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbi.2016.07.144","article-title":"Effects of immune activation during early or late gestation on schizophrenia-related behaviour in adult rat offspring","volume":"63","author":"Meehan","year":"2017","journal-title":"Brain Behav Immun"},{"key":"key\n\t\t\t\t20180820115501_CIT0089","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/oxfordjournals.schbul.a033453","article-title":"Maternal exposure to respiratory infections and adult schizophrenia spectrum disorders: a prospective birth cohort study","volume":"26","author":"Brown","year":"2000","journal-title":"Schizophr Bull"},{"key":"key\n\t\t\t\t20180820115501_CIT0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbi.2016.09.008","article-title":"Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: a prospective birth cohort study","volume":"59","author":"Metcalf","year":"2017","journal-title":"Brain Behav Immun"},{"key":"key\n\t\t\t\t20180820115501_CIT0091","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1176\/appi.ajp.2011.11030516","article-title":"Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study","volume":"168","author":"Benros","year":"2011","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0092","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-6632.2012.06638.x","article-title":"Autoimmune diseases and infections as risk factors for schizophrenia","volume":"1262","author":"Benros","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20180820115501_CIT0093","doi-asserted-by":"crossref","first-page":"15979","DOI":"10.1073\/pnas.0806485105","article-title":"Three-dimensional brain growth abnormalities in childhood-onset schizophrenia visualized by using tensor-based morphometry","volume":"105","author":"Gogtay","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180820115501_CIT0094","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1192\/bjp.188.6.510","article-title":"Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies","volume":"188","author":"Steen","year":"2006","journal-title":"Br J Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1741-7015-4-29","article-title":"Grey matter changes can improve the prediction of schizophrenia in subjects at high risk","volume":"4","author":"Job","year":"2006","journal-title":"BMC Med"},{"key":"key\n\t\t\t\t20180820115501_CIT0096","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1192\/bjp.186.1.26","article-title":"Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia","volume":"186","author":"Chakos","year":"2005","journal-title":"Br J Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0097","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1176\/appi.ajp.158.8.1316","article-title":"Association of an interleukin-1beta genetic polymorphism with altered brain structure in patients with schizophrenia","volume":"158","author":"Meisenzahl","year":"2001","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0098","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000070857","article-title":"Assessment of neuroinflammation and microglial activation in Alzheimer\u2019s disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study","volume":"50","author":"Versijpt","year":"2003","journal-title":"Eur Neurol"},{"key":"key\n\t\t\t\t20180820115501_CIT0099","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.biopsych.2008.04.025","article-title":"Microglia activation in recent-onset schizophrenia: a quantitative \u00ae-[11C]PK11195 positron emission tomography study","volume":"64","author":"van Berckel","year":"2008","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0100","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2967\/jnumed.109.066647","article-title":"Neuroinflammation in schizophrenia-related psychosis: a PET study","volume":"50","author":"Doorduin","year":"2009","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t20180820115501_CIT0101","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1017\/S1461145710000313","article-title":"Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106","volume":"13","author":"Takano","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"key\n\t\t\t\t20180820115501_CIT0102","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/mp.2016.247","article-title":"Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [11C]PBR28","volume":"22","author":"Collste","year":"2017","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0103","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/mp.2017.232","article-title":"Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry","volume":"23","author":"Notter","year":"2018","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0104","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/schbul\/sbt139","article-title":"Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update","volume":"40","author":"Sommer","year":"2014","journal-title":"Schizophr Bull"},{"key":"key\n\t\t\t\t20180820115501_CIT0105","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1176\/appi.ajp.159.6.1029","article-title":"Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia","volume":"159","author":"M\u00fcller","year":"2002","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0106","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00406-004-0548-4","article-title":"Clinical effects of COX-2 inhibitors on cognition in schizophrenia","volume":"255","author":"M\u00fcller","year":"2005","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"key\n\t\t\t\t20180820115501_CIT0107","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.biopsych.2005.02.024","article-title":"Celecoxib augmentation of continuously ill patients with schizophrenia","volume":"57","author":"Rapaport","year":"2005","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0108","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.schres.2010.04.015","article-title":"Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment","volume":"121","author":"M\u00fcller","year":"2010","journal-title":"Schizophr Res"},{"key":"key\n\t\t\t\t20180820115501_CIT0109","first-page":"31","article-title":"COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence","volume":"11","author":"M\u00fcller","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"key\n\t\t\t\t20180820115501_CIT0110","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4088\/JCP.09m05117yel","article-title":"Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial","volume":"71","author":"Laan","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0111","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4088\/JCP.10r06823","article-title":"Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis","volume":"73","author":"Sommer","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0112","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/schbul\/sbt070","article-title":"Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials","volume":"39","author":"Nitta","year":"2013","journal-title":"Schizophr Bull"},{"key":"key\n\t\t\t\t20180820115501_CIT0113","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.schres.2006.11.016","article-title":"Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial","volume":"90","author":"Akhondzadeh","year":"2007","journal-title":"Schizophr Res"},{"key":"key\n\t\t\t\t20180820115501_CIT0114","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1176\/ajp.152.9.1291","article-title":"Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status","volume":"152","author":"McAllister","year":"1995","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0920-9964(98)00034-6","article-title":"The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6","volume":"32","author":"Lin","year":"1998","journal-title":"Schizophr Res"},{"key":"key\n\t\t\t\t20180820115501_CIT0116","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/sj.npp.1300756","article-title":"Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics","volume":"30","author":"Zhang","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t20180820115501_CIT0117","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/schbul\/sbv028","article-title":"Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis","volume":"41","author":"Mondelli","year":"2015","journal-title":"Schizophr Bull"},{"key":"key\n\t\t\t\t20180820115501_CIT0118","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jad.2012.03.033","article-title":"Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study","volume":"141","author":"Abbasi","year":"2012","journal-title":"J Affect Disord"},{"key":"key\n\t\t\t\t20180820115501_CIT0119","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0120","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1089\/089771502753754091","article-title":"Cyclooxygenase-2 inhibition protects cultured cerebellar granule neurons from glutamate-mediated cell death","volume":"19","author":"Strauss","year":"2002","journal-title":"J Neurotrauma"},{"key":"key\n\t\t\t\t20180820115501_CIT0121","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00213-007-0955-0","article-title":"Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice","volume":"196","author":"Mizoguchi","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"key\n\t\t\t\t20180820115501_CIT0122","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4088\/JCP.08m04666yel","article-title":"A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia","volume":"71","author":"Levkovitz","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0123","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/0269881112444941","article-title":"Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment","volume":"26","author":"Chaudhry","year":"2012","journal-title":"J Psychopharmacol"},{"key":"key\n\t\t\t\t20180820115501_CIT0124","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.pnpbp.2007.01.018","article-title":"Possible anti-catatonic effects of minocycline in patients with schizophrenia","volume":"31","author":"Ahuja","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0125","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.4088\/JCP.14l09005","article-title":"Adjunctive recombinant human interferon gamma-1b for treatment-resistant schizophrenia in 2 patients","volume":"75","author":"Gr\u00fcber","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t20180820115501_CIT0126","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.psc.2016.01.003","article-title":"The case for adjunctive monoclonal antibody immunotherapy in schizophrenia","volume":"39","author":"Miller","year":"2016","journal-title":"Psychiatr Clin North Am"},{"key":"key\n\t\t\t\t20180820115501_CIT0127","doi-asserted-by":"crossref","DOI":"10.1159\/000470802","article-title":"Neuroprogression in schizophrenia and psychotic disorder: the possible role of inflammation","volume-title":"Neuroprogression in Psychiatric Disorders","author":"M\u00fcller","year":"2017"}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/44\/5\/973\/25516134\/sby024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T21:26:00Z","timestamp":1751491560000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article\/44\/5\/973\/4965841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,10]]},"references-count":127,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,4,10]]},"published-print":{"date-parts":[[2018,8,20]]}},"URL":"https:\/\/doi.org\/10.1093\/schbul\/sby024","relation":{},"ISSN":["0586-7614","1745-1701"],"issn-type":[{"value":"0586-7614","type":"print"},{"value":"1745-1701","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,9]]},"published":{"date-parts":[[2018,4,10]]}}}